Live from the NIH registry
Studies recruiting near Burlington right now
Top 25 of 748 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cone Health Cancer Center at Alamance Regional — Burlington, North Carolina (2.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UNC Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
University of North Carolina Medical Center ( Site 0136) — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Daiichi Sankyo
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
UNC Hospitals Adult Oncology Clinics — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: C4 Therapeutics, Inc.
Registry for Adults With Plasma Cell Disorders (PCD's)
Multiple Myeloma, Amyloidosis
N/A
Observational 2,000 participants sought
North Carolina Cancer Hospital — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
UNC- Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Guardant Health, Inc.
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
Endometriosis
Phase 2
Interventional 24 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of North Carolina, Chapel Hill
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Headache Wellness Center /ID# 270568 — Greensboro, North Carolina (18.1 mi)
· Sponsor: AbbVie
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy
Breast Cancer, Quality of Life
Phase 2
Interventional 90 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 4
Interventional 65 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Takeda
Feasibility Test of Action Planning in Pediatric IBD
Inflammatory Bowel Diseases
N/A
Interventional 60 participants sought
University of North Carolina-Chapel Hill School of Medicine — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of North Carolina, Chapel Hill
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Pfizer
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Cone Health Cancer Center at Alamance Regional — Burlington, North Carolina (2.2 mi)
· Sponsor: NRG Oncology
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of North Carolina-Hillsborough Campus — Hillsborough, North Carolina (20.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Relapsed or Resistant Acute Leukaemias
Phase 1, Phase 2
Interventional 90 participants sought
UNC Hospitals, The University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Lin BioScience, Inc
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Phase 1, Phase 2
Interventional 287 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Janssen Research & Development, LLC
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of North Carolina, Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Kura Oncology, Inc.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Pulmonix LLC — Greensboro, North Carolina (18.1 mi)
· Sponsor: Duke University
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
Hearing Loss, Unilateral, Deafness, Unilateral
N/A
Interventional 60 participants sought
University of North Carolina — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: Cochlear
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Acute HIV Infection
Phase 2
Interventional 48 participants sought
3203, Greensboro CRS — Greensboro, North Carolina (18.1 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Medically Tailored Meals for Kids
Pediatric Cancer
N/A
Interventional 30 participants sought
North Carolina Basnight Cancer Hospital — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
UNC Hospitals — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Mitigating PTSD-CUD After Sexual Assault
Posttraumatic Stress Disorder, Cannabis Use Disorder
Phase 1, Phase 2
Interventional 68 participants sought
UNC Chapel Hill — Chapel Hill, North Carolina (25.7 mi)
· Sponsor: University of Nevada, Las Vegas